Literature DB >> 2369292

Exercise reconditioning in the rehabilitation of patients with chronic obstructive pulmonary disease: a short- and long-term analysis.

P M Swerts1, L M Kretzers, E Terpstra-Lindeman, F T Verstappen, E F Wouters.   

Abstract

The short- and long-term outcome of exercise reconditioning on exercise tolerance and breathlessness scores were evaluated in a group of patients with severe chronic obstructive pulmonary disease (COPD). After a combined initial program of eight weeks, the patients were randomized into two groups: group A followed a supervised training program for another 12 weeks; group B was discharged after this initial program and received written instructions to continue exercise training at home. The patients were evaluated at the start, after the initial eight weeks' training, after six months, and after one year. For the total group, exercise tolerance, assessed by 12-minute walking distance, increased significantly from 784m to 848m (p less than .05) after the initial program. Neither breathlessness scores nor spirometric data changed significantly. In group A, the increase in exercise tolerance persisted not only at the end of the continued training program but even at the end of the one-year follow-up. In group B, there was a progressive and significant decline of exercise tolerance during the one-year follow-up. Our data confirm that even in severe COPD patients, exercise tolerance can increase significantly without any change in spirometric data and without an increased tolerance for the sensation of dyspnea. A supervised training program must be continued to stabilize the obtained effects because even when an initial improvement is experienced, patients may lack motivation to continue an unsupervised training program.

Entities:  

Mesh:

Year:  1990        PMID: 2369292

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  7 in total

Review 1.  Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.

Authors:  M Decramer; R Gosselink; P Bartsch; C-G Löfdahl; W Vincken; R Dekhuijzen; J Vestbo; R Pauwels; R Naeije; T Troosters
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

2.  Efficacy of a simple and inexpensive exercise training program for advanced chronic obstructive pulmonary disease patients in community hospitals.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 3.  Home versus center based physical activity programs in older adults.

Authors:  N L Ashworth; K E Chad; E L Harrison; B A Reeder; S C Marshall
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 4.  Supervised maintenance programmes following pulmonary rehabilitation compared to usual care for chronic obstructive pulmonary disease.

Authors:  Carla Malaguti; Simone Dal Corso; Sadia Janjua; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2021-08-17

5.  Long-term efficacy of intensive cycle ergometer exercise training program for advanced COPD patients.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk; Chalerm Liwsrisakun; Chaiwat Bumroongkit; Athavudh Deesomchok; Theerakorn Theerakittikul; Atikun Limsukon
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-12

Review 6.  Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis.

Authors:  Alex R Jenkins; Holly Gowler; Ffion Curtis; Neil S Holden; Christopher Bridle; Arwel W Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-10

7.  Effect of a pulmonary rehabilitation programme of 8 weeks compared to 12 weeks duration on exercise capacity in people with chronic obstructive pulmonary disease (PuRe Duration): protocol for a randomised controlled trial.

Authors:  Joshua Bishop; Lissa Spencer; Jennifer Alison
Journal:  BMJ Open Respir Res       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.